Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement
Clinical trial NCT05127421 · COMPLETED
Trial details
- NCT number
- NCT05127421
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2023-08-03
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.